Importer of Controlled Substances Registration, 2571 [2019-01521]
Download as PDF
2571
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Drug
code
Controlled substance
Beta-hydroxythiofentanyl .........................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................................
Amphetamine ...........................................................................................................................................................................
Methamphetamine ...................................................................................................................................................................
Codeine ...................................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................................
Oxycodone ...............................................................................................................................................................................
Hydromorphone .......................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................................
Isomethadone ..........................................................................................................................................................................
Methadone ...............................................................................................................................................................................
Methadone intermediate ..........................................................................................................................................................
Morphine ..................................................................................................................................................................................
Thebaine ..................................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................................
Oxymorphone ..........................................................................................................................................................................
Thiafentanil ..............................................................................................................................................................................
Alfentanil ..................................................................................................................................................................................
Sufentanil .................................................................................................................................................................................
Carfentanil ...............................................................................................................................................................................
Fentanyl ...................................................................................................................................................................................
The company plans to manufacture
the listed controlled substances to make
reference standards which will be
distributed to their customers.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
[FR Doc. 2019–01510 Filed 2–6–19; 8:45 am]
ACTION:
Notice of registration.
BILLING CODE 4410–09–P
The registrant listed below
has applied for and been granted a
SUMMARY:
FR Docket
Sigma Aldrich Co., LLC .................................................................................................................................
83 FR 60903
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
Dated: January 3, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01521 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Research Triangle
Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 11, 2019. Such persons
may also file a written request for a
DATES:
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
registration by the Drug Enforcement
Administration (DEA) as an importer of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for this notice.
Company
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrant to import the applicable
basic classes of schedule I and II
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security system, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I and II controlled substances
to the above listed company.
9836
9843
1100
1105
9050
9120
9143
9150
9193
9226
9250
9254
9300
9333
9648
9652
9729
9737
9740
9743
9801
Schedule
Published
November 27, 2018.
hearing on the application on or before
March 11, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
E:\FR\FM\07FEN1.SGM
07FEN1
Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Page 2571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01521]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted a
registration by the Drug Enforcement Administration (DEA) as an
importer of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as an importer of various basic classes of controlled
substances. Information on the previously published notice is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for this notice.
----------------------------------------------------------------------------------------------------------------
Company FR Docket Published
----------------------------------------------------------------------------------------------------------------
Sigma Aldrich Co., LLC................... 83 FR 60903 November 27, 2018.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrant to
import the applicable basic classes of schedule I and II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated the company's
maintenance of effective controls against diversion by inspecting and
testing the company's physical security system, verifying the company's
compliance with state and local laws, and reviewing the company's
background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I and II controlled substances to the above
listed company.
Dated: January 3, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01521 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P